Delivery Order SPE2DB24D2216-SPE2DB24FGMFS
Award Date
7/5/24
Potential Completion Date
7/8/24
Potential Value
$42K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of KISQALI 200 MG DAILY DOSE UU 21S pharmaceutical products to the Defense Logistics Agency (DLA). The $6,903.84 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 29, 2025 and is not designated as a set-aside award. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical and medical products to the U.S. government. The award, valued at $9,923.50, is for the delivery of a specific pharmaceutical product, KISQALI 600 MG DAILY DOSE 63S. The contract has a completion date of July 12, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,793.24 Firm Fixed Price Delivery Order contract is for the supply of KISQALI 600 MG DAILY DOSE 63S, a pharmaceutical product. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,662.57 firm fixed-price delivery order is for KISQALI 600 MG DAILY DOSE 63S, a pharmaceutical product. The contract has an ultimate completion date of January 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $14,077.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of November 6, 2023. The award is for the delivery of KISQALI 400 MG DAILY DOSE 42S, a pharmaceutical product. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product KISQALI 200 MG DAILY DOSE UU 21S. The contract, awarded by the Defense Logistics Agency (DLA), has a ceiling value of $17,572.15 and a completion date of May 13, 2024. It is a Firm Fixed Price Delivery Order contract with no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, is a Delivery Order valued at $12,277.94. The contract is for the provision of the drug KISQALI 600 MG DAILY DOSE 63S to the Defense Logistics Agency (DLA), a defense agency that provides logistics and acquisition support to the U.S. Armed Forces. The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $17,730.75, is for the supply of KISQALI 400 mg daily dose prescription medication. The contract has an ultimate completion date of January 30, 2025 and is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award is between the Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,555.45 delivery order is for the supply of KISQALI 400 MG DAILY DOSE 42S, a specialty medication. The contract has a firm fixed-price pricing type and an ultimate completion date of December 18, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a large pharmaceutical distributor, for the delivery of KISQALI 400 MG DAILY DOSE 42S, a medical product. The firm-fixed-price Delivery Order contract has a ceiling value of $42,816.16 and an ultimate completion date of August 19, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp's Corporate Office division holds this contract,...